Efficacy of clozapine in a non‐schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis | Zendy

Mauri M. C. | Zendy; Volonteri L. S. | Zendy; Fiorentini A. | Zendy; Dieci M. | Zendy; Righini A. | Zendy; Vita A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Efficacy of clozapine in a non‐schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis

Author(s) -

Mauri M. C.,

Volonteri L. S.,

Fiorentini A.,

Dieci M.,

Righini A.,

Vita A.

Publication year - 2002

Publication title -

human psychopharmacology: clinical and experimental

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.461

H-Index - 78

eISSN - 1099-1077

pISSN - 0885-6222

DOI - 10.1002/hup.407

Subject(s) - polydipsia , clozapine , central pontine myelinolysis , psychogenic disease , medicine , schizophrenia (object oriented programming) , psychology , atypical antipsychotic , antipsychotic , pediatrics , psychiatry , hyponatremia , endocrinology , diabetes mellitus

Clozapine is an atypical antipsychotic drug that has been demonstrated to be a highly effective treatment for polydipsia in schizophrenic patients. The authors report the first case of a non‐schizophrenic patient affected by polydipsia and central pontine myelinolysis who was successfully treated with clozapine. Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research